Cargando…

TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points

OBJECTIVE: To evaluate the onset of efficacy of TEV-48125, a monoclonal antibody against calcitonin gene-related peptide, recently shown to be effective for the preventive treatment of chronic migraine (CM) and high-frequency episodic migraine. METHODS: A randomized placebo-controlled study tested o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bigal, Marcelo E., Dodick, David W., Krymchantowski, Abouch V., VanderPluym, Juliana H., Tepper, Stewart J., Aycardi, Ernesto, Loupe, Pippa S., Ma, Yuju, Goadsby, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932236/ https://www.ncbi.nlm.nih.gov/pubmed/27281531 http://dx.doi.org/10.1212/WNL.0000000000002801

Ejemplares similares

Fremanezumab for preventive treatment of migraine: Functional status on headache-free days
por: VanderPluym, Juliana, et al.
Publicado: (2018)

Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine
por: Krymchantowski, Abouch Valenty, et al.
Publicado: (2004)

Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders
por: Krymchantowski, Abouch Valenty, et al.
Publicado: (2011)

Fremanezumab in the treatment of migraines: evidence to date
por: Robblee, Jennifer, et al.
Publicado: (2019)

Ubrogepant in the Acute Management of Migraine: A Narrative Review
por: Chiang, Chia-Chun, et al.
Publicado: (2021)

Profile of Lasmiditan in the Acute Treatment of Migraine in Adults: Design, Development, and Place in Therapy
por: Anderson, Christopher C, et al.
Publicado: (2023)

Acute treatment of migraine. Breaking the paradigm of monotherapy
por: Krymchantowski, Abouch Valenty
Publicado: (2004)

The use of combination therapies in the acute management of migraine
por: Krymchantowski, Abouch Valenty
Publicado: (2006)

Medication-Overuse Headache: Differences between Daily and Near-Daily Headache Patients
por: Krymchantowski, Abouch V., et al.
Publicado: (2016)

Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study
por: Krymchantowski, Abouch V., et al.
Publicado: (2023)

Correction: Krymchantowski, A.V.; et al. Medication-Overuse Headache: Differences between Daily and Near-Daily Headache Patients; Brain Sciences 2016, 6, 30
por: Krymchantowski, Abouch V., et al.
Publicado: (2017)

Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study
por: Lipton, Richard B., et al.
Publicado: (2021)

Evaluation of the Safety of Calcitonin Gene-Related Peptide Antagonists for Migraine Treatment Among Adults With Raynaud Phenomenon
por: Breen, Ilana D., et al.
Publicado: (2021)

Indomethacin for refractory COVID or post-COVID headache: a retrospective study
por: Krymchantowski, Abouch V., et al.
Publicado: (2021)

Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials
por: Ashina, Messoud, et al.
Publicado: (2021)

The global burden of migraine
por: Lipton, Richard B., et al.
Publicado: (2003)

Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult‐to‐Treat Migraine Headaches
por: Tepper, Stewart J., et al.
Publicado: (2019)

Overview on the prevalence and impact of migraine
por: Bigal, Marcelo E., et al.
Publicado: (2004)

Medication-overuse headache—a review of different treatment strategies
por: Krymchantowski, Abouch, et al.
Publicado: (2023)

Is there an inherent limit to acute migraine treatment efficacy?
por: Bigal, Marcelo E., et al.
Publicado: (2009)

Migraine and behavior in children: influence of maternal headache frequency
por: Arruda, Marco A., et al.
Publicado: (2012)

Humanistic and economic burden of nausea and vomiting among migraine sufferers
por: Gajria, Kavita, et al.
Publicado: (2017)

Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial
por: Lipton, Richard B, et al.
Publicado: (2021)

Psychosis and Bilateral Peripheral Facial Palsy Associated With COVID-19
por: Jevoux, Carla, et al.
Publicado: (2022)

Migraine headache is present in the aura phase – a prospective study
por: Hansen, JM, et al.
Publicado: (2013)

EHMTI-0178. CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study
por: Goadsby, P, et al.
Publicado: (2014)

2 Cases of Spontaneous Coronary Artery Dissection in Neonates
por: Bassi, Sunakshi, et al.
Publicado: (2022)

Efficacy, Tolerability, and Safety of DFN‐15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study
por: Lipton, Richard B., et al.
Publicado: (2019)

Migraine attacks the Basal Ganglia
por: Maleki, Nasim, et al.
Publicado: (2011)

Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach
por: Sperotto, Francesca, et al.
Publicado: (2020)

A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)
por: Starling, Amaal J, et al.
Publicado: (2018)

Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study
por: Saper, Joel R, et al.
Publicado: (2011)

Pathophysiology of migraine
por: Goadsby, Peter J.
Publicado: (2012)

Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study
por: Goadsby, Peter J., et al.
Publicado: (2020)

Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post‐Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial
por: Dodick, David W., et al.
Publicado: (2018)

Risk of hypertension in erenumab‐treated patients with migraine: Analyses of clinical trial and postmarketing data
por: Dodick, David W., et al.
Publicado: (2021)

Vascular safety of erenumab for migraine prevention
por: Kudrow, David, et al.
Publicado: (2020)

Migraine and cardiovascular disease: systematic review and meta-analysis
por: Schürks, Markus, et al.
Publicado: (2009)

Understanding the migraine treatment landscape prior to the introduction of calcitonin gene‐related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study
por: Kawata, Ariane K., et al.
Publicado: (2021)

Prophylaxis of migraine: general principles and patient acceptance
por: D’Amico, Domenico, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_p8snnrs142jhlisucmhvgn9e5d